0
0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Product Insights

    $2,000 | January 2024
    Product Insights

    Zika Virus Infections – Drugs In Development, 2023

    Global Markets Direct’s, ‘Zika Virus Infections - Drugs In Development, 2023’, provides an overview of the Zika Virus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Zika Virus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Trypanosomiasis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Trypanosomiasis - Drugs In Development, 2023’, provides an overview of the Trypanosomiasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Trypanosomiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Chikungunya Fever – Drugs In Development, 2023

    Global Markets Direct’s, ‘Chikungunya Fever - Drugs In Development, 2023’, provides an overview of the Chikungunya Fever pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chikungunya Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Plague – Drugs In Development, 2023

    Global Markets Direct’s, ‘Plague - Drugs In Development, 2023’, provides an overview of the Plague pipeline landscape. The report provides comprehensive information on the therapeutics under development for Plague, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Pulmonary Inflammation – Drugs In Development, 2023

    Global Markets Direct’s, ‘Pulmonary Inflammation - Drugs In Development, 2023’, provides an overview of the Pulmonary Inflammation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pulmonary Inflammation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Typhoid Fever – Drugs In Development, 2023

    Global Markets Direct’s, ‘Typhoid Fever - Drugs In Development, 2023’, provides an overview of the Typhoid Fever pipeline landscape. The report provides comprehensive information on the therapeutics under development for Typhoid Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Anaphylaxis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Anaphylaxis - Drugs In Development, 2023’, provides an overview of the Anaphylaxis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anaphylaxis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Hand, Foot and Mouth Disease – Drugs In Development, 2023

    Global Markets Direct’s, ‘Hand, Foot and Mouth Disease - Drugs In Development, 2023’, provides an overview of the Hand, Foot and Mouth Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hand, Foot and Mouth Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Mycobacterium tuberculosis Infections – Drugs In Development, 2023

    Global Markets Direct’s, ‘Mycobacterium tuberculosis Infections - Drugs In Development, 2023’, provides an overview of the Mycobacterium tuberculosis Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mycobacterium tuberculosis Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Tuberculosis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Tuberculosis - Drugs In Development, 2023’, provides an overview of the Tuberculosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Tuberculosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.